We are live on !
Find out more
NF Trinity Capital Portfolio holdings
AUM
$626M
Turnover
24%
1-Year Est. Return
3.16%
This Fund
S&P 500
This Quarter Est. Return
+10.41%
1 Year Est. Return
+3.16%
3 Year Est. Return
+49.61%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$739M
AUM Growth
+$27.3M
(+3.8%)
Cap. Flow
-$140M
Cap. Flow % of AUM
Cap. Flow %
-18.98%
Top 10 Holdings %
Top 10 Hldgs %
63.17%
Holding
47
New
4
Increased
2
Reduced
8
Closed
1
Avg Time Held
Equity + Options
0.8
years
Top 10 Avg Time Held
Equity + Options
1
year
Top 20 Avg Time Held
Equity + Options
1
year
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
1
year
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$5.27M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$4.97M |
| 3 |
Palo Alto Networks
PANW
|
+$4.7M |
| 4 |
Lockheed Martin
LMT
|
+$3.14M |
| 5 |
PayPal
PYPL
|
+$1.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$8.19M |
| 2 |
Baidu
BIDU
|
+$7.08M |
| 3 |
NXP Semiconductors
NXPI
|
+$6.44M |
| 4 |
Universal Display
OLED
|
+$4.47M |
| 5 |
Walt Disney
DIS
|
+$3.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 26.29% |
| 2 | Miscellaneous | 25.59% |
| 3 | Healthcare | 13.48% |
| 4 | Consumer Discretionary | 11.97% |
| 5 | Financials | 10.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Alibaba
BABA
$235B
| $76M | 10.28% |
704,382
| – | – |
2015 Q4
5 quarters
|
|
2
Bank of America
BAC
$349B
| $61.7M | 8.35% |
2,616,982
-128,000
| -5% | -$3.04M |
2015 Q4
5 quarters
|
|
3
Apple
AAPL
$5.16T
| $54.8M | 7.41% |
1,525,588
| – | – |
2015 Q4
5 quarters
|
|
4
Alphabet (Google) Class A
GOOGL
$3.67T
| $49.5M | 6.69% |
1,166,800
| – | – |
2015 Q4
5 quarters
|
|
|
5
Baidu
BIDU
$26.4B
| $46M | 6.22% |
266,470
-40,230
| -13% | -$7.08M |
2015 Q4
5 quarters
|
|
|
6
Walt Disney
DIS
$204B
| $44.6M | 6.03% |
393,230
-34,000
| -8% | -$3.74M |
2015 Q4
5 quarters
|
|
7
Meta Platforms (Facebook)
META
$1.59T
| $42.3M | 5.72% |
297,800
| – | – |
2015 Q4
5 quarters
|
|
|
8
iShares Biotechnology ETF
IBB
$11.1B
| $38.8M | 5.25% |
397,050
-85,500
| -18% | -$8.19M |
2015 Q4
5 quarters
|
|
|
AGN
9
DELISTED
Allergan plc
AGN
| $25.8M | 3.5% |
108,148
-13,000
| -11% | -$3.03M |
2015 Q4
5 quarters
|
|
10
State Street Health Care Select Sector SPDR ETF
XLV
$50.7B
| $21.6M | 2.92% |
290,100
| – | – |
2015 Q4
5 quarters
|
|
11
State Street Energy Select Sector SPDR ETF
XLE
$42.2B
| $17.6M | 2.38% |
502,560
| – | – |
2015 Q4
5 quarters
|
|
12
JD.com
JD
$37.1B
| $12.5M | 1.69% |
400,724
| – | – |
2016 Q1
4 quarters
|
|
13
Bristol-Myers Squibb
BMY
$127B
| $10.1M | 1.37% |
186,000
| – | – |
2015 Q4
5 quarters
|
|
|
14
Universal Display
OLED
$4.05B
| $9.29M | 1.26% |
107,889
-62,111
| -37% | -$4.47M |
2016 Q3
2 quarters
|
|
|
CELG
15
DELISTED
Celgene Corp
CELG
| $8.82M | 1.19% |
70,917
-31,000
| -30% | -$3.71M |
2015 Q4
5 quarters
|
|
16
Liberty Global Class A
LBTYA
$3.54B
| $8.51M | 1.15% |
237,371
| – | – |
2015 Q4
5 quarters
|
|
|
17
Lockheed Martin
LMT
$140B
| $8.03M | 1.09% |
30,000
+12,000
| +67% | +$3.14M |
2016 Q1
4 quarters
|
|
18
Neurocrine Biosciences
NBIX
$17.1B
| $7.93M | 1.07% |
183,202
| – | – |
2016 Q3
2 quarters
|
|
19
Mastercard
MA
$569B
| $7.8M | 1.06% |
69,400
| – | – |
2015 Q4
5 quarters
|
|
20
Biogen
BIIB
$37B
| $6.56M | 0.89% |
24,000
| – | – |
2015 Q4
5 quarters
|
|
21
Citigroup
C
$205B
| $6.1M | 0.83% |
101,930
| – | – |
2015 Q4
5 quarters
|
|
22
Gilead Sciences
GILD
$208B
| $5.91M | 0.8% |
86,959
| – | – |
2015 Q4
5 quarters
|
|
|
ALXN
23
DELISTED
Alexion Pharmaceuticals
ALXN
| $5.58M | 0.75% |
46,000
| – | – |
2016 Q3
2 quarters
|
|
|
24
PayPal
PYPL
$48.4B
| $5.42M | 0.73% |
125,900
+47,400
| +60% | +$1.98M |
2016 Q3
2 quarters
|
|
|
25
Edwards Lifesciences
EW
$60.8B
| $5.28M | 0.71% |
+168,243
| New | +$5.27M |
2017 Q1
0 quarters
|
|
Similar funds
SHCM
IAS
NF Trinity Capital's Q1 2017 Portfolio in Review
As of Q1 2017, NF Trinity Capital held 47 positions worth $739M, up 3.8% from $712M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
NF Trinity Capital withdrew a net $140M in Q1 2017, closing 1 position and reducing 8 holdings. Its most notable exit was NXP Semiconductors, an estimated $6.44M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 26% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, NF Trinity Capital opened a new position in Edwards Lifesciences worth $5.28M.
- NF Trinity Capital's largest Q1 2017 buy was Edwards Lifesciences: 168,243 shares worth $5.28M.
- NF Trinity Capital added most to Lockheed Martin in Q1 2017, an estimated $3.14M increase.
- NF Trinity Capital's biggest Q1 2017 reduction was iShares Biotechnology ETF, cutting an estimated $8.19M.
- NF Trinity Capital fully exited NXP Semiconductors in Q1 2017, selling an estimated $6.44M.
- NF Trinity Capital's ten largest holdings make up 63% of its $739M portfolio in Q1 2017.
- NF Trinity Capital opened 4 new positions and closed 1 in Q1 2017.
- NF Trinity Capital's portfolio value rose 3.8% quarter-over-quarter to $739M.
Based on NF Trinity Capital's 13F filing for Q1 2017, filed 5 May 2017.